Pressure Ulcers Treatment Market

Pressure Ulcers Treatment Focus on Wound Care Products is Expected to be Flourished by Advancements in Chronic Wound Care Technologies


Pressure ulcers, also known as bedsores or pressure injuries, are injuries to the skin and underlying tissues that result from sustained pressure on the skin. The consequences of prolonged pressure lead to damage of blood vessels and interruption of blood flow. Common causes include sitting or lying in one position for long periods, medical conditions that reduce mobility, or limited sensation and ability to feel discomfort. Pressure ulcers can range from skin discoloration to tissue death and severe muscle and bone damage. Products used for prevention and treatment include wound dressings, skin protectants, special beds, mattresses, spacers and overlays.

The Global Pressure Ulcers Treatment Market Size is estimated to be valued at US$ 6045.54 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Advancements in chronic wound care technologies continue to shape the market landscape with development of innovative products that aid faster healing and prevent infection and complications. For instance, advanced wound dressings infused with growth factors, hydrogels and skin substitute technologies are gaining prominence.

Market Dynamics

Focus on advancement in chronic wound care technologies remains a key market driver. Chronic and hard-to-heal wounds impose significant burden on healthcare systems. Novel products in the pipeline promise advanced healing capabilities through cellular and tissue regeneration approaches. Biomaterial-based scaffolds, skin and soft tissue substitutes, stem cell therapies and gene therapies hold potential to transform wound management. Success of these therapies in clinical trials will further boost market growth prospects over the forecast period. Rapid commercialization of effective solutions for diabetic foot ulcers, pressure ulcers and venous leg ulcers will garner major market demand.

Segment Analysis

The pressure ulcers treatment market can be segmented into dressings, drug, devices, and others. Among them, the dressings segment dominates the market and accounts for over 40% market share owing to the high demand for dressing products such as hydrocolloid dressings, hydrogel dressings, silicone dressings, and foam dressings to promote wound healing.

PEST Analysis

Political: Governments across countries are focusing on reducing healthcare costs which is driving them to work on prevention of pressure ulcers. They are issuing guidelines to healthcare facilities for proper protocols.
Economic: Rising geriatric population and chronic diseases are influencing the economic growth of this market. However, healthcare cost containment efforts of governments can restrict market growth to some extent.
Social: With increasing awareness, people are more inclined towards timely prevention and treatment of pressure ulcers. This helps in speedy recovery and better quality of life.
Technological: Companies are developing advanced wound dressings, diagnostics tools and other treatment devices incorporating latest technologies. Use of artificial intelligence and 3D printing offers new opportunities.

Key Takeaways

The global pressure ulcers treatment market is expected to witness high growth.


Regional analysis – North America holds the largest share in the global market owing to growing elderly population, high healthcare spending and presence of key players. Asia Pacific is expected to grow at the fastest pace during the forecast period on back of improving access to healthcare facilities and healthcare infrastructure development in emerging nations like India and China.

Key players operating in the pressure ulcers treatment market are DIC Corporation (Japan), Dow Chemical Company (US), BASF SE (Germany), Arkema Group (France), Celanese Corporation (US), Trinseo (US), The Lubrizol Corporation (US), Wacker Chemie AG (Germany), Synthomer Plc (UK), and Asahi Kasei Corporation (Japan). These leading players are focused on new product launches, partnerships and mergers & acquisitions to expand their global reach. For instance, Dow Chemical Company provides advanced silicones and biosciences solutions for wound care management.

1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it